Imaging software developer Definiens will be holding its 3rd International Definiens Symposium at its headquarters in Munich on 14-16 June.
The program will feature the latest trends in quantitative digital pathology and tissue-based biomarker development with leading experts from Roche, AstraZeneca, Novartis, as well as biomedical image and data analysis during hands-on workshops, Definiens said.
